ArticleBMC microbiology2026
Evaluation of AI-enhanced FTIR spectroscopy for species and biovar typing of intracellular pathogenic Brucella spp.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRapid and accurate identification of intracellular pathogenic Brucella species and biovars is essential for effective public health surveillance, outbreak control, and preservation of animal and human health. While traditional biotyping remains the gold standard for biovar classification, it is time-consuming, technically demanding, dangerous, and costly. We validated artificial intelligence (AI)-coupled Fourier-transform infrared (FTIR) spectroscopy for Brucella biotyping as a faster, automated, and cost-effective alternative.
resultsOne hundred and sixty-three strains of different species and biovars, originating from humans and animals, were assessed. The FTIR achieved high accuracy across all assessed species, achieving 95-100% sensitivity and specificity. On the biovar level, differentiating also vaccine from wild type strains, it achieved 80-100% sensitivity and specificity, depending on the species and the number of available strains for different biovars.
conclusionsOur research shows the identification of the FTIR as a highly robust and automated high-throughput method. This approach generates real-time data that shows potential for real-time epidemiological surveillance and allows early detection of outbreaks caused by zoonotic pathogens. By integrating classical microbiological methods with AI, the method shows great promise for its applicability in routine laboratory work and a high-throughput, fast, simple, safe, and cost-effective strategy for epidemiological surveillance of intracellular pathogenic Brucella bacteria on a global scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.